Completed PHASE2 INTERVENTIONAL 2-arm NCT02006719

Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder (AC)

A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder

Sponsor: Endo Pharmaceuticals

Conditions Adhesive Capsulitis Frozen Shoulder

Interventions Collagenase Clostridium Histolyticum Placebo

Updated 7 times since 2017 Last updated: Sep 7, 2017 Started: Nov 30, 2013 Primary completion: Dec 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Adhesive Capsulitis and Frozen Shoulder, this trial is completed. The trial is conducted by Endo Pharmaceuticals and has accumulated 7 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jul 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jul 2017 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Nov 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Endo Pharmaceuticals

Data source: Endo Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Altoona, United States , Arlington, United States , Bedford, United States , Bend, United States , Birmingham, United States , Boise, United States , Carlsbad, United States , Danville, United States , DeLand, United States , Durham, United States and 30 more locations